FDA OK’s biosimilair drug of Amgen’s Neupogen chemo recovery drug
The FDA has recently approved a biosimilair drug in the US. The approval of the drug will have far reaching consequences for the multibillion dollar biologic drug market. What exactly is a Biogenic drug and why...